<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Insider Trading Headlines for Friday March 24th 2017 | Insider Insights</title>
<link href="http://www.insiderinsights.com/insider-news-headlines/2017-03-24" ></link>
<id>urn:uuid:b8ceabf0-c4dd-9b75-1065-696f310d0c08</id>
<updated>2026-09-19T10:33:07-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ABT: CONTRERAS JAIME (VP) Acquired (JB) 394 Shares of ABBOTT LABORATORIES for $0.00 on 3/21</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3319781" ></link>
<id>urn:uuid:68760fbc-4fd8-7247-0ce9-9c182f6c938b</id>
<updated>2017-03-24T17:06:16-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT). Recent Price: $102.61. Mkt Cap:177.6B. 10D Vol: 9.7mm]]></summary>
</entry>
<entry>
<title>ABT: CONTRERAS JAIME (VP) Disposed (JS) 394 Shares of ABBOTT LABORATORIES for $0.00 on 3/21</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3319782" ></link>
<id>urn:uuid:5b9591c4-3af9-9e15-23ca-3d393ea5c5ad</id>
<updated>2017-03-24T17:06:16-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT). Recent Price: $102.61. Mkt Cap:177.6B. 10D Vol: 9.7mm]]></summary>
</entry>
<entry>
<title>AGIO: CANTLEY LEWIS CLAYTON JR (DIR) Sold (AS) 1,018 Shares of AGIOS PHARMACEUTICALS INC for $52.31-$53.91 on 3/22-3/23</title>
<link href="http://www.insiderinsights.com/company/agio/agios-pharmaceuticals-inc/id-3319653" ></link>
<id>urn:uuid:208c3cd0-e033-4cf5-e676-2799013044ee</id>
<updated>2017-03-24T16:20:54-04:00</updated>
<summary type="html" ><![CDATA[AGIOS PHARMACEUTICALS INC (AGIO). Recent Price: $33.07. Mkt Cap:2.0B. 10D Vol: 932,650]]></summary>
</entry>
<entry>
<title>AGIO: CANTLEY LEWIS CLAYTON JR (DIR) Sold (AS) 1,018 Shares of AGIOS PHARMACEUTICALS INC for $52.31-$53.91 on 3/22-3/23</title>
<link href="http://www.insiderinsights.com/company/agio/agios-pharmaceuticals-inc/id-3319654" ></link>
<id>urn:uuid:88ff1d7a-4205-5a30-5ef8-8da6846ebb10</id>
<updated>2017-03-24T16:20:54-04:00</updated>
<summary type="html" ><![CDATA[AGIOS PHARMACEUTICALS INC (AGIO). Recent Price: $33.07. Mkt Cap:2.0B. 10D Vol: 932,650]]></summary>
</entry>
<entry>
<title>ADBE: LEWNES ANN (VP,SO) Sold (AS) 2,233 Shares of ADOBE SYSTEMS INC for $125.00 on 3/22</title>
<link href="http://www.insiderinsights.com/company/adbe/adobe-systems-inc/id-3319615" ></link>
<id>urn:uuid:d9863d5e-697d-37c4-8dfa-c398d3291da9</id>
<updated>2017-03-24T16:05:38-04:00</updated>
<summary type="html" ><![CDATA[ADOBE SYSTEMS INC (ADBE). Recent Price: $248.92. Mkt Cap:98.9B. 10D Vol: 6.8mm]]></summary>
</entry>
<entry>
<title>ACGL: PAPADOPOULO NICOLAS (CEO) Filed a Form 3, Becoming a Registered Insider at ARCH CAPITAL GROUP LTD With Initial Direct Holdings of 254,024</title>
<link href="http://www.insiderinsights.com/company/acgl/arch-capital-group-ltd/id-3319605" ></link>
<id>urn:uuid:cf392525-ee33-4342-109c-a4f84a59b469</id>
<updated>2017-03-24T15:49:18-04:00</updated>
<summary type="html" ><![CDATA[ARCH CAPITAL GROUP LTD (ACGL). Recent Price: $96.89. Mkt Cap:33.1B. 10D Vol: 4.3mm]]></summary>
</entry>
<entry>
<title>ACNB: SITES DAVID L (DIR) Bought (B) 2k Shares of ACNB CORP for $28.50 on 3/22</title>
<link href="http://www.insiderinsights.com/company/acnb/acnb-corp/id-3319554" ></link>
<id>urn:uuid:7d6cbed5-ec07-c04e-1aa2-a1ee931d11c0</id>
<updated>2017-03-24T14:22:34-04:00</updated>
<summary type="html" ><![CDATA[ACNB CORP (ACNB). Recent Price: $64.57. Mkt Cap:656.7mm. 10D Vol: 78,020]]></summary>
</entry>
</feed>